prld (PRLD) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.59

Median Target+74.29%

$8.00

Potential upside vs current price

DCF Value-19.49%

$3.70

Potential downside vs current price

Current Stock Price

$4.59

Median Target+74.29%

$8.00

Potential upside vs current price

DCF Value-19.49%

$3.70

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.59

Median Target+74.29%

$8.00

Potential upside vs current price

DCF Value-19.49%

$3.70

Potential downside vs current price

Current Stock Price

$4.59

Median Target+74.29%

$8.00

Potential upside vs current price

DCF Value-19.49%

$3.70

Potential downside vs current price

Prelude Therapeutics Incorporated